Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8914–8916.

https://doi.org/10.1182/blood-2022-158686

Published: 2022

Journal Articles

The Presence of Minimal Residual Disease, As Determined By Highly Sensitive Quantitation of NPM1 -Mutatation, Provided Powerful Prognostic Information in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 5097.

https://doi.org/10.1182/blood-2019-127725

Published: 2019

Journal Articles

The Prognostic Impact of KIT D816 Mutations in Core Binding Factor Acute Myeloid Leukemia

Blood (2016) 128 (22): 2785.

https://doi.org/10.1182/blood.V128.22.2785.2785

Published: 2016

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Yosuke Tanaka, MD, Saiko Kurosawa, MD, Kinuko Tajima, Yoshihiro Inamoto, MD PhD, Reiko Ito, MD, Takashi Tanaka, MD, Yoshitaka Inoue, MD, Takayuki Ozawa, MD, Akihisa Kawajiri, MD, Akio Onishi, MD, Keiji Okinaka, MD, Shigeo Fuji, MD, Sung-Won Kim, MD, Ryuji Tanosaki, MD PhD, Takuya Yamashita, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 3162.

https://doi.org/10.1182/blood.V126.23.3162.3162

Published: 2015

Journal Articles

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Blood (2014) 124 (21): 1221.

https://doi.org/10.1182/blood.V124.21.1221.1221

Published: 2014

Journal Articles

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Takahiko Nakane, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Saiko Kurosawa, MD, Atsuo Okamura, MD, PhD, Michihiro Hidaka, MD, PhD, Takuya Yamashita, MD, PhD, Akio Kohno, MD, PhD, Takeshi Saito, MD, Yasutaka Aoyama, MD, PhD, Kazuo Hatanaka, MD, Yoshio Katayama, MD, PhD, Kimikazu Yakushijin, MD, PhD, Toshimitsu Matsui, MD, PhD, Akiyoshi Takami, MD, PhD, Takuhiro Yamaguchi, PhD, Masayuki Hino, MD, PhD, Takahiro Fukuda, MD

Blood (2013) 122 (21): 4586.

https://doi.org/10.1182/blood.V122.21.4586.4586

Published: 2013

Journal Articles

Intravenous Busulfan-Based Myeloablative Conditioning Is Comparable to TBI-Based Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Recipients with Acute Myeloid Leukemia: A Nationwide Retrospective Study From the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

Takuya Yamashita, M.D., Ph.D., Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Kazuteru Ohashi, M.D., Saiko Kurosawa, M.D., Yasuo Morishima, M.D., Tokiko Nagamura, MD, PhD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, PhD, Akiyoshi Takami, MD, PhD, FJSIM

Blood (2012) 120 (21): 1922.

https://doi.org/10.1182/blood.V120.21.1922.1922

Published: 2012

Journal Articles

High Non-Relapse Mortality and Low Relapse Incidence in Sex-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation From Female Donor with Male Child

Akihito Shinohara, M.D., Ph.D., Nobuhiro Hiramoto, MD, Saiko Kurosawa, M.D., Ryosuke Ueda, MD, Takashi Tanaka, MD, Kohei Tada, MD, Yujin Kobayashi, MD, Noriyuki Morikawa, MD, Keiji Okinaka, MD, Kinuko Tajima, Takuya Yamashita, M.D., Ph.D., Mineo Kurokawa, M.D., Takahiro Fukuda, MD, PhD

Blood (2012) 120 (21): 1945.

https://doi.org/10.1182/blood.V120.21.1945.1945

Published: 2012

Journal Articles

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Nobuhiro Hiramoto, MD, Kinuko Tajima, Saiko Kurosawa, MD, Takuya Yamashita, MD, Kenji Okinaka, MD, Noriyuki Morikawa, MD, Kohei Tada, MD, Takashi Tanaka, MD, Ryosuke Ueda, MD, Yujin Kobayashi, MD, Akihito Shinohara, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 2033.

https://doi.org/10.1182/blood.V118.21.2033.2033

Published: 2011

Journal Articles

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Ryuji Tanosaki, M.D., Tomoko Kumazawa, M.T., Shigehisa Yoshida, M.T., Atsuya Nakano, M.T., Shizuka Yamagata, M.T., Noriko Takahashi, M.T., Saiko Kurosawa, MD, Shin-Ichiro Mori, M.D., Yuji Heike, MD, Takahiro Fukuda, MD, Ko Furuta, M.D., Hitoshi Tsuda, M.D.

Blood (2011) 118 (21): 1922.

https://doi.org/10.1182/blood.V118.21.1922.1922

Published: 2011

Journal Articles

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Ryosuke Ueda, MD, Nobuhiro Hiramoto, MD, Shin-Ichiro Mori, MD, Saiko Kurosawa, MD, Takashi Tanaka, MD, Kohei Tada, MD, Yujin Kobayashi, MD, Noriyuki Morikawa, MD, Akihito Shinohara, MD, Keiji Okinaka, MD, Takuya Yamashita, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 4542.

https://doi.org/10.1182/blood.V118.21.4542.4542

Published: 2011

Journal Articles

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Masato Watanabe, Kazuaki Yakushiji, Shingo Yano, Yuichiro Nawa, Jun Taguchi, Jin Takeuchi, Junji Tomiyama, Yuko Nakamura, Ikuo Miura, Yoshinobu Kanda, Yoichi Takaue, Takahiro Fukuda

Blood (2011) 117 (7): 2113–2120.

https://doi.org/10.1182/blood-2010-05-285502

Published: 2011

Includes: Supplemental data

Journal Articles

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

Saiko Kurosawa, Kimikazu Yakushijin, Takuhiro Yamaguchi, Yoshiko Atsuta, Tokiko Nagamura-Inoue, Hideki Akiyama, Shuichi Taniguchi, Koichi Miyamura, Satoshi Takahashi, Tetsuya Eto, Yasuo Morishima, MD, Hisashi Sakamaki, Takahiro Fukuda

Blood (2010) 116 (21): 901.

https://doi.org/10.1182/blood.V116.21.901.901

Published: 2010

Journal Articles

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Kohei Tada, MD, Sung-Won Kim, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Kimikazu Yakushijin, MD, Saiko Kurosawa, MD, Niina Ueno, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Shinichiro Mori, MD, Yuji Heike, MD, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 3508.

https://doi.org/10.1182/blood.V116.21.3508.3508

Published: 2010

Journal Articles

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Takeshi Maeda, MD, Kimikazu Yakushijin, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Saiko Kurosawa, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Niina Ueno, MD, Sung-Won Kim, MD, Shin-Ichiro Mori, MD, Ryuji Tanosaki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 2318.

https://doi.org/10.1182/blood.V116.21.2318.2318

Published: 2010

Journal Articles

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Blood (2009) 114 (22): 2281.

https://doi.org/10.1182/blood.V114.22.2281.2281

Published: 2009

Journal Articles

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Toru Sakura, Kensuke Usuki, Masato Watanabe, Takuya Yamashita, Heiwa Kanamori, Junji Tomiyama, Yuichiro Nawa, Shingo Yano, Jin Takeuchi, Kazuaki Yakushiji, Fumiaki Sano, Nobuhiko Uoshima, Yasuhito Nannya, Yoshiyuki Moriuchi, Yoichi Takaue, Takahiro Fukuda

Blood (2009) 114 (22): 524.

https://doi.org/10.1182/blood.V114.22.524.524

Published: 2009

Journal Articles

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Kimikazu Yakushijin, Takahiro Fukuda, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Daisuke Nakamura, Kohei Tada, Masaaki Nishinohara, Akihito Hagiwara, Niina Ueno, Yutaro Kamiyama, Masakazu Mori, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Yoichi Takaue

Blood (2009) 114 (22): 3353.

https://doi.org/10.1182/blood.V114.22.3353.3353

Published: 2009

Journal Articles

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Ryuji Tanosaki, Kimikazu Yakushijin, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Masakazu Mori, Takahiro Fukuda, Sung-Won Kim, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Yoichi Takaue

Blood (2009) 114 (22): 3370.

https://doi.org/10.1182/blood.V114.22.3370.3370

Published: 2009

NARROW

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

The Presence of Minimal Residual Disease, As Determined By Highly Sensitive Quantitation of NPM1 -Mutatation, Provided Powerful Prognostic Information in Acute Myeloid Leukemia

The Prognostic Impact of KIT D816 Mutations in Core Binding Factor Acute Myeloid Leukemia

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

High Non-Relapse Mortality and Low Relapse Incidence in Sex-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation From Female Donor with Male Child

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only